Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$5.77 - $20.25 $40,401 - $141,790
-7,002 Reduced 36.54%
12,159 $176,000
Q4 2023

Feb 13, 2024

BUY
$6.11 - $14.1 $117,073 - $270,170
19,161 New
19,161 $176,000
Q2 2022

Aug 15, 2022

BUY
$21.88 - $57.86 $530,393 - $1.4 Million
24,241 New
24,241 $541,000
Q2 2021

Aug 13, 2021

SELL
$88.36 - $141.98 $578,227 - $929,117
-6,544 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$109.42 - $157.18 $716,044 - $1.03 Million
6,544 New
6,544 $718,000
Q2 2020

Aug 14, 2020

SELL
$29.72 - $81.28 $188,930 - $516,696
-6,357 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$29.49 - $102.99 $56,738 - $198,152
1,924 Added 43.4%
6,357 $222,000
Q4 2019

Feb 13, 2020

BUY
$33.02 - $64.96 $146,377 - $287,967
4,433 New
4,433 $279,000

Others Institutions Holding CDLX

About Cardlytics, Inc.


  • Ticker CDLX
  • Exchange NASDAQ
  • Sector Communication Services
  • Industry Advertising Agencies
  • Shares Outstandng 32,893,800
  • Market Cap $127M
  • Description
  • Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...
More about CDLX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.